Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/innovent-and-anheart-therapeutics-announce-the-nmpa-of-china-has-accepted-second-nda-for-taletrectinib-for-first-line-treatment-of-ros1-positive-lung-cancer-302079359.html